Gut Bacteria Restoration Cuts Inflammation in Injured Mice
The research-stage mouse findings suggest gut-based approaches could one day aid spinal cord injury recovery, pending human studies.
Updated on Nov. 2, 2026 in Science

Ohio State University researchers reported that restoring a gut bacteria strain depleted after spinal cord injury reduced inflammation and stabilized weight loss in mice. The findings are research-stage, based on animal experiments rather than any treatment available to people.
Why it matters
The work points to the gut as a possible lever in recovery after spinal cord injury, since injury can disrupt signaling between the brain and organs including the gut. A separate study linking 19 bacterial species to nitrogen changes after injury adds to a growing picture of how the gut microbiome responds to neurological damage.
The evidence comes from mouse experiments in which researchers compared injured animals against uninjured controls over six months. Analysis of 333 fecal samples produced 6,635 draft microbial genomes, covering an estimated 80% of the gut microbiome in one commonly used mouse strain, but whether these mouse results translate to human recovery has not been established.
The players
The Ohio State University
A major public research university in Columbus, Ohio, with active work in neuroscience and microbiome research.
The details
Researchers compared mice with injuries at different levels of the thoracic spinal cord against animals without spinal cord damage. They traced shifts in nitrogen balance to the depletion of bacteria that convert a compound into a usable form of nitrogen, a nutrient the body needs to build proteins. Lactobacillus johnsonii, a gut bacterium, was consistently depleted in injured mice, and restoring the depleted strain reduced inflammation.
Timeline
Researchers tracked changes in injured mice over six months.
The Tech Race
The work sits within a broader research effort to map how gut bacteria influence nervous system recovery, an area where mouse studies remain the main evidence base. Its two published papers, in NPJ Biofilms and Microbiomes and Communications Biology, add concrete findings to that line of inquiry.
This is research-stage work in mice, and no treatment based on restoring these gut bacteria is available to patients. Any clinical application would require further study to determine whether similar approaches can safely and effectively improve recovery in people, with no timeline announced.
The takeaway
Watch for follow-up studies testing whether restoring these gut bacteria can aid recovery beyond mice. The two published papers in NPJ Biofilms and Microbiomes and Communications Biology are the primary record to track for further results.
Further reading
Explore more Life Sciences coverage to see how microbiome research is reshaping medicine.
Source note: This article includes information reported by WOWO 1190 AM | 107.5 FM.




